Main navigation
What We Do
What We Do
Investment Banking
Public Finance
Research
Fixed Income
Alternative Asset Management
Equities
Sectors
Sectors
Chemicals
Consumer
Education
Energy, Power & Infrastructure
Financial Services
Financial Sponsors
Government
Healthcare
Real Estate
Services & Industrials
Technology
About
About
Who We Are
Our Commitments
Our People
News & Insights
Conferences & Events
Careers
Investor Relations
Transactions
Transactions
Investment Banking
Public Finance
Contact
Search
Invalid search inquiry
Log In
Log In
Client Account Access
Fixed Income Client Portal
Merchant Banking Investor Access
Research Access
Read more
about Immuneering Corp - 2025/12/08
$100.0 Million
Image
Immuneering Corp
ATM Program Common Stock
Sole Sales Agent
Read more
about Bright Minds Biosciences - 2025/19/08
$100.0 Million
Image
Bright Minds Biosciences
ATM Program Common Stock
Lead Sales Agent
Read more
about American Bitcoin - 2025/09/03
$2.1 Billion
Image
American Bitcoin
ATM Program Common Stock
Co-Manager
Read more
about Commercial Credit Group Inc. - 2025/08/14
$75.0 Million
Image
Commercial Credit Group Inc.
Senior Unsecured Notes
Sole Placement Agent
Read more
about ProFrac Holding Corp. - 2025/08/12
$75.0 Million
Image
ProFrac Holding Corp.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about Compass Therapeutics LLC - 2025/08/14
$120.0 Million
Image
Compass Therapeutics
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about Miami International Holdings, Inc. - 2025/08/15
$396.7 Million
Image
Miami International Holdings, Inc.
Initial Public Offering
Active Bookrunner
Read more
about Avidbank Holdings, Inc. - 2025/08/07
$60.0 Million
Image
Avidbank Holdings, Inc
Initial Public Offering
Joint Bookrunner
Read more
about HeartFlow, Inc. - 2025/08/12
$316.6 Million
Image
HeartFlow
Initial Public Offering
Active Bookrunner
Read more
about ImmunityBio - 2025/07/25
$80.0 Million
Image
ImmunityBio
Registered Direct Offering
Sole Placement Agent
Pagination
Previous page
‹‹
Page 4
Next page
››
Subscribe to Equity Capital Markets